3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
6
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
8
Myelodysplastic Syndromes
5
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Recurrence
2
Primary Myelofibrosis
2
Neoplasms, Plasma Cell
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Hematologic Diseases
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
selinexor
1
liposomal doxorubicin
1
ixazomib
1
fludarabine phosphate
1
Temozolomide
1
PM 01183
1
Melphalan
1
Irinotecan
1
Erlotinib Hydrochloride
1
Electroacupuncture
1
Busulfan
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Sarcoma, Ewing
×
Busulfan
×
Clear all
NCT01969942
2017-05-09
ASCT
University of Louisville
Phase 1
Withdrawn